04:15 AM EDT, 07/02/2026 (MT Newswires) -- Craig C. Hopkinson, Executive Vice President of Research and Development and Chief Medical Officer, on July 01, 2026, sold 9,000 shares in Alkermes ( ALKS ) for $463,621. Following the Form 4 filing with the SEC, Hopkinson has control over a total of 73,389 ordinary shares of the company, with 73,389 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1520262/000152026226000103/xslF345X05/form4.xml